|
Market Closed -
NYSE
16:00:00 2026-08-18 EDT
|
5-day change | 1st Jan Change | ||
| 2.340 USD | +2.18% |
|
-5.65% | +30.00% |
| 08-12 | Protalix BioTherapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Other Pharmaceuticals | +2.18% | -5.65% | +30.00% | +58.11% | +70.80% | 185M |  |  | |
- Stock Market
- Stocks
- PLX Stock
- Charts Protalix BioTherapeutics, Inc.
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
